Profile data is unavailable for this security.
About the company
ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.
- Revenue in GBP (TTM)2.02m
- Net income in GBP-18.03m
- Incorporated2003
- Employees150.00
- LocationAngle PLCThe Surrey Research Park, 10 Nugent RoadGUILDFORD GU2 7AFUnited KingdomGBR
- Phone+44 148 334 3434
- Fax+44 148 368 5836
- Websitehttps://www.angleplc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexstim Oyj | 6.59m | -693.18k | 29.05m | 39.00 | -- | 18.69 | -- | 4.41 | -0.1223 | -0.1223 | 1.19 | 0.2761 | 0.8196 | 0.2223 | 5.28 | 214,040.30 | -8.62 | -26.77 | -14.02 | -43.90 | 97.24 | 92.11 | -10.52 | -38.38 | 1.24 | -5.51 | 0.7716 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
| BrainCool AB (publ) | 2.69m | -4.14m | 29.30m | 20.00 | -- | 2.65 | -- | 10.89 | -0.2635 | -0.2635 | 0.1695 | 0.6071 | 0.2378 | 2.01 | 3.76 | 1,561,500.00 | -36.54 | -47.14 | -39.83 | -70.16 | -32.65 | -149.77 | -153.65 | -391.45 | 3.64 | -5.86 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| Integrum AB | 7.34m | -181.23k | 30.31m | 36.00 | -- | 2.35 | 556.82 | 4.13 | -0.1244 | -0.1244 | 5.29 | 9.58 | 0.5706 | 0.5666 | 3.59 | 2,620,068.00 | -1.41 | -1.71 | -1.55 | -1.98 | 87.25 | 83.87 | -2.47 | -2.87 | 5.54 | -0.6636 | 0.0325 | -- | 40.19 | 35.91 | 124.92 | -- | 127.10 | -- |
| Bioretec Oy | 3.39m | -2.94m | 30.80m | 43.00 | -- | 5.72 | -- | 9.08 | -0.1752 | -0.1752 | 0.2024 | 0.318 | 0.4104 | 1.23 | 3.75 | 110,166.80 | -35.54 | -66.83 | -40.92 | -97.19 | 69.97 | 70.97 | -86.61 | -133.49 | 4.04 | -- | 0.0696 | -- | 32.78 | 19.77 | -54.02 | -- | -- | -- |
| Svas Biosana SpA | 101.12m | 4.54m | 31.92m | 327.00 | 6.71 | 0.6194 | 3.77 | 0.3156 | 1.02 | 1.02 | 22.76 | 11.06 | 0.7926 | 2.82 | 2.84 | 376,254.20 | 3.56 | 2.72 | 5.83 | 4.72 | 25.79 | 28.12 | 4.49 | 3.78 | 1.42 | 3.81 | 0.5187 | -- | 21.66 | 11.34 | 43.52 | 21.76 | 13.33 | -- |
| Modulight Oyj | 2.87m | -9.86m | 32.62m | 79.00 | -- | 0.7545 | -- | 11.37 | -0.2844 | -0.2844 | 0.0836 | 1.22 | 0.0516 | -0.3111 | 1.94 | 49,271.43 | -17.72 | -8.39 | -18.97 | -9.10 | 123.49 | 114.69 | -343.58 | -56.81 | 4.50 | -- | 0.0965 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Ondine Biomedical Inc | 929.32k | -8.12m | 33.19m | 43.00 | -- | 2,095.79 | -- | 35.71 | -0.0368 | -0.0368 | 0.0042 | 0.00004 | 0.2859 | 0.5497 | 9.93 | -- | -249.74 | -- | -597.99 | -- | 60.04 | -- | -873.56 | -- | 0.4828 | -- | 0.9487 | -- | 88.56 | -- | 25.60 | -- | -- | -- |
| ANGLE plc | 2.02m | -18.03m | 35.49m | 150.00 | -- | 1.45 | -- | 17.53 | -0.0684 | -0.0684 | 0.0077 | 0.076 | 0.0553 | 0.3117 | 1.21 | 13,493.33 | -49.30 | -- | -55.77 | -- | 69.07 | -- | -890.91 | -- | 4.80 | -- | 0.1469 | -- | 109.99 | -- | 7.17 | -- | -- | -- |
| Substrate Artificial Inteligence SA | 11.40m | -5.06m | 37.35m | 17.00 | -- | 0.3891 | -- | 3.28 | -0.2262 | -0.2262 | 0.2148 | 0.2878 | 0.3905 | 0.2868 | 6.52 | 806,132.90 | -15.79 | -- | -20.57 | -- | 97.35 | -- | -40.44 | -- | 0.591 | -12.93 | 0.141 | -- | 174.53 | -- | 42.10 | -- | -- | -- |
| MeVis Medical Solutions AG | 14.68m | 4.79m | 38.16m | 111.00 | 7.97 | 2.57 | 7.82 | 2.60 | 3.16 | 3.16 | 9.69 | 9.79 | 0.7128 | -- | 7.95 | 174,693.80 | 23.24 | 22.74 | 28.00 | 29.85 | 97.24 | 96.90 | 32.60 | 35.45 | -- | -- | 0.00 | 27.86 | -7.57 | -0.4922 | -36.84 | -8.38 | -17.46 | 0.00 |
| AbL Diagnostics SA | 4.91m | 153.64k | 38.35m | 17.00 | 249.56 | 6.72 | 52.27 | 7.81 | 0.0115 | 0.0115 | 0.3664 | 0.4254 | 0.3942 | -- | 1.61 | 368,863.10 | 1.23 | 3.24 | 2.14 | 4.43 | -- | -- | 3.13 | 8.81 | 1.92 | -64.06 | 0.3109 | -- | -35.84 | 74.86 | -95.08 | -49.30 | 7.81 | -- |
| Mentice AB | 19.72m | -1.67m | 38.56m | 130.00 | -- | 3.87 | 172.32 | 1.96 | -0.9104 | -0.9104 | 10.71 | 5.42 | 0.9243 | 2.77 | 4.38 | 2,250,394.00 | -7.84 | -7.69 | -15.21 | -13.07 | 85.89 | 83.67 | -8.48 | -10.00 | 0.9251 | -- | 0.0285 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Medicalgorithmics SA | 6.71m | -1.95m | 39.08m | 120.00 | -- | 2.44 | -- | 5.82 | -1.02 | -1.02 | 3.52 | 8.39 | 0.3048 | 0.6718 | 8.57 | 291,900.00 | -8.85 | -0.9441 | -9.71 | -1.18 | 80.08 | 89.46 | -29.05 | -2.19 | 1.65 | -- | 0.0513 | 0.00 | -31.28 | -26.39 | -102.27 | -- | -18.81 | -- |
| Carmat SA | 4.60m | -44.39m | 39.79m | 162.00 | -- | -- | -- | 8.65 | -1.76 | -1.76 | 0.1787 | -0.6419 | 0.0932 | 1.61 | 1.28 | 30,379.12 | -89.92 | -76.92 | -113.71 | -94.38 | -535.50 | -- | -964.91 | -4,636.64 | 1.69 | -17.37 | 1.63 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
| Tissue Regenix Group PLC | 25.26m | -874.78k | 41.26m | 76.00 | -- | 1.73 | 1,366.62 | 1.63 | -0.0124 | -0.0124 | 0.3581 | 0.3343 | 0.7061 | 1.33 | 6.41 | 332,416.70 | -2.17 | -13.45 | -2.43 | -14.78 | 49.48 | 45.90 | -3.08 | -28.80 | 1.47 | 0.3716 | 0.263 | -- | 20.50 | 13.75 | 36.44 | -- | 9.78 | -- |
Data as of Nov 22 2024. Currency figures normalised to Angle PLC's reporting currency: UK Pound GBX
21.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Global Frontier Investments LLCas of 11 Jul 2024 | 22.09m | 6.85% |
| Hargreaves Lansdown Asset Management Ltd.as of 01 Nov 2024 | 10.63m | 3.29% |
| Baillie Gifford & Co.as of 23 Jun 2023 | 8.06m | 2.50% |
| Chelverton Asset Management Ltd.as of 31 Dec 2023 | 7.51m | 2.33% |
| Aegon Asset Management UK PLCas of 06 Jan 2024 | 5.30m | 1.64% |
| IG Markets Ltd.as of 01 Nov 2024 | 4.10m | 1.27% |
| KW Investment Management Ltd.as of 01 Nov 2024 | 3.19m | 0.99% |
| Evelyn Partners Investment Management LLPas of 01 Nov 2024 | 2.93m | 0.91% |
| Unicorn Asset Management Ltd.as of 01 Nov 2024 | 2.77m | 0.86% |
| United Nations Joint Staff Pension Fundas of 01 Nov 2024 | 2.50m | 0.78% |
More ▼
Data from 30 Jun 2024 - 05 Nov 2024Source: FactSet Research Systems Inc.
